Direct Oral Anticoagulants (DOACs) are a class of medications used to prevent and treat blood clots. They work by directly inhibiting specific proteins in the blood that are involved in the clotting process, reducing the risk of conditions like deep vein thrombosis and pulmonary embolism. Common DOACs include apixaban, rivaroxaban, and dabigatran. Unlike traditional anticoagulants such as warfarin, DOACs do not require regular blood monitoring and have fewer dietary restrictions. They are typically taken in fixed doses, making them more convenient for patients. However, it is essential to follow a healthcare provider's guidance when using these medications.